Summary:
Meridien Research is conducting a 54-week research study to assess the safety and effects of an investigational intravenous (IV) migraine drug.
No medical insurance is necessary. Contact Meridien Research today to find out if you qualify.
Qualified Participants Must:
• Be between 18 and 55 years of age
•
Have had migraines in the past year
Qualified Participants May Receive:
Evaluations, physical exams, routine lab work, investigational drug or placebo, and compensation for time and travel may be available.